Trial Profile
A Prospective Study Assessing the Efficacy and Safety of BF-200 ALA with Photodynamic Therapy (PDT) for the Treatment of Bowen's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Bowen's disease
- Focus Adverse reactions; Therapeutic Use
- 10 May 2018 New trial record